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Abstract 
The adsorption and insertion kinetics for the association of two 34-residue cyclic 
peptides with phosphocholine membranes have been studied using circular and linear 
dichroism approaches. The two peptides studied are identical with the exception of 
two residues, which are both tyrosine in one of the peptides and tryptophan in the 
other. Both peptides adopt random coil conformations in solution in the absence of 
membranes and do not aggregate at concentrations below 20 micromolar. Following 
addition to liposome dispersions, circular dichroism (CD) spectroscopy indicated that 
both peptides undergo an extremely rapid transformation to a beta-conformation that 
remains unchanged throughout the remainder of the experiment. Linear dichroism 
(LD) spectroscopy was used to study the kinetics of membrane adsorption and 
insertion. The data were analyzed by non-linear least squares approaches, leading to 
identification of a number of bound states and their corresponding LD spectra. Two 
pseudo-first order processes could be identified that were common to both peptides. 
The first occurred with a time constant of the order of 1 min and led to a bound state 
characterized by weak LD signals, with significant bands corresponding to the 
transitions of aromatic side chains. The second process occurred with an unusually 
long time constant of between 75 and 100 min, forming a state with considerably 
stronger positive LD absorbance in the far-UV region of the spectrum. For the 
tyrosine-substituted peptide, a third slow process with a long time constant (76 min) 
could also be delineated and was attributed to rearrangements of the peptide within 
the membrane. 
 
Introduction 
There has been much speculation in recent years concerning the roles of aromatic 
amino acids in the interactions of proteins and peptides with lipid bilayers (1-4). 
Recent studies have suggested that tryptophan in particular, has significant 
interactions with lipids, utilising the hydrogen bonding donor potential of the indole 
ring combined with a possible role for cation-π interactions of the large aromatic ring 
system (5,6). Tyrosine has also been found to have significant interactions with 
phospholipid headgroups (5,1,2). 
From data produced by studies on model transmembrane peptides (7,8) it is clear that 
tryptophan plays a key role in membrane anchoring, with NMR evidence suggesting 
that the indole group of the tryptophan side chain interacts with lipid acyl carbonyl 
groups (9); recent experiments with ether lipids have demonstrated similar peptide 
behaviours to those observed with acyl lipids (10). These experiments, however, have 
generally been restricted to transmembrane species that are helical in nature. 
Systematic studies on model transmembrane β-peptides have been conducted less 
frequently, despite the relative abundance of stable membrane proteins and 
antimicrobial peptides rich in β-structure. Experiments on short tryptophan- and 
leucine-rich β-sheet peptides have highlighted the particular importance of hydrogen 
bond formation in the low dielectric membrane environment, (11,12) and 
demonstrated that significant changes in behaviour can occur in response to single 
amino acid changes, particularly concerning substitutions for tryptophan. Similar 
modifications to the membrane activities of β-sheet peptides following single amino 
acid substitutions for tryptophan have been demonstrated elsewhere, (13) raising 
questions with regard to the mechanisms that control the membrane insertion and 
stability of peptides.  
 
In order to obtain mechanistic information, it is desirable to have access to both 
kinetic and structural information during the insertion process itself. Circular 
dichroism (CD) spectroscopy has proved to be a useful tool for monitoring the 
conformations of peptides in membrane-associated and free forms, but does not reveal 
information concerning the location of the peptide within the membrane. Oriented CD 
(14-18) and linear dichroism (LD) approaches have been used to address this concern. 
LD reveals the orientation of electronic transitions with respect to the experimental 
frame of reference and can therefore furnish information on the orientation of 
peptides with respect to membranes, provided that the latter can be aligned. The 
development of a low volume Couette cell (19,20) has allowed facile measurement of 
LD spectra from membrane-bound species in shear-aligned liposomes (21,22). This 
has been used to study the alignments of cell-penetrating peptides and was able to 
correlate reduced membrane penetrating ability with α-helix alignment in the plane of 
the membrane (23). Combined CD and LD studies on gramicidin have enabled 
probing of the tryptophan side chains in the β6.3 conformation of the peptide, with 
the axis of the peptide found to align along the bilayer normal and the tryptophan side 
chains to adopt orientations away from the plane of the membrane (21). This 
approach therefore has the potential to allow both peptide structure and membrane 
alignment to be probed as a function of time, enabling insertion kinetics to be 
determined with greater certainty. 
 
In previous work (24), we described a cyclic peptide system that was able to porate 
liposomal membranes with high efficacy. In this paper we describe spectroscopic 
experiments concerning this and a related peptide (Fig. 1) that demonstrate that these 
peptides undergo a range of kinetic processes following binding to membranes, some 
of which exhibit much slower kinetics than anticipated. The data further highlight the 
differential effects of tyrosine and tryptophan in relation to membrane anchoring and 
demonstrate the potential for deconvoluting LD data to reveal details of intermediate 
states in the insertion process. 
 
Materials and Methods 
Materials 
All amino acids, benzotriazole-1-yl-oxy-tris-pyrrolidino-phosphonium 
hexafluorophosphate (PyBOP) and the solid support (Novasyn TGR) were purchased 
from Novabiochem (UK). 1,1,1,3,3,3-Hexafluoroisopropanol (HFIP) and 2,2,2-
trifluoroethanol (TFE) were purchased from Fluorochem (UK) and distilled before 
use. All other solvents and reagents, including N,N-dimethylformamide (DMF), 1-
hydroxybenzotriazole (HOBt), N,N-diisopropylethylamine (DIEA), N-
methylmorpholine (NMM), N,N-diethyldithiocarbamate, sodium salt (DEDC), 
trifluoroacetic acid (TFA), 1,2-ethanedithiol (EDT), triisopropylsilane (TIS) and 2-(4-
hydroxyphenylazo)benzoic acid (HABA) were purchased from Aldrich (UK), Fisher 
Scientific (UK) or Lancaster Synthesis (UK) and used without further purification.  
For lipsome preparation, egg phosphatidylcholine (EPC; 100 mg/ml in chloroform) 
was purchased from Sigma and 100 nm laser-etched polycarbonate membranes from 
Whatman (UK). 
 
Peptide Chain Assembly 
Peptides 1 and 2 were synthesized by batch solid-phase peptide synthesis under a  
nitrogen atmosphere at room temperature on an Advanced Chemtech 348Ω 
synthesizer using a Novasyn TGR solid support (0.29 mmol/g; 0.10 g, 0.03 mmol) 
and Fmoc protection strategies. Coupling of amino acids was performed for 1 h in  
DMF (2.5 ml) using PyBOP (5 eq) in the presence of HOBt (5 eq) and DIEA (10 eq). 
Deprotection between cycles was conducted with 20% v/v piperidine in DMF (2 x 2 
ml). The solid support was washed with DMF after each coupling and Fmoc-
deprotection step (2 × 2.5 ml and 4 × 2.5 ml respectively). In the first cycle, N-α-
Fmoc-L-aspartic acid α-allyl ester (Fmoc-Asp-OAll) was double-coupled to the solid 
support. Valine, leucine, tryptophan and tyrosine residues were added as 
pseudoproline dipeptides (Fmoc-Val-Ser(ψMe,MePro)-OH, Fmoc-Leu-Ser(ψMe,MePro)-
OH, Fmoc-Trp(Boc)-Ser(ψMe,MePro)-OH, Fmoc-Tyr(tBu)-Ser(ψMe,MePro)-OH). (25) 
Following peptide assembly, a small portion (~5 mg) of the resin was removed for 
analysis.  
 
Peptide Cyclization 
The resin was washed with CH2Cl2 (3 × 2 ml) and then treated with CH2Cl2 (2 ml) and 
a freshly-prepared solution of tetrakis(triphenylphosphine)palladium(0) in 
CHCl3/AcOH/NMM (37:2:1; 30 mM, 1.5 ml). (26) The mixture was agitated for 2 h at room temperature before being washed successively with DIEA (0.5 M in DMF, 
3.3 ml) and DEDC (0.3 M in DMF, 2.5 ml) and DMF (2 × 3 ml). The resin was then 
treated with a solution of DIEA (0.026 g, 0.15 mmol), HOBt (0.023 g, 0.15 mmol) 
and PyBOP (0.078 g, 0.15 mmol) in DMF (3 ml) for 5 h at room temperature before 
being washed successively with DMF (4 × 1.5 ml), MeOH (5 × 2 ml) and CH2Cl2 (5 × 
2 ml) and dried under a stream of nitrogen for 30 min. This yielded 0.19 g and 0.18 g 
of peptide-bound resin for 1 and 2 respectively. 
 
Cleavage of Peptides from the Solid Support 
Cleavage of the peptide was conducted when necessary by treating portions of the 
resin (50 mg) with a mixture of TFA/water/EDT/TIS (9.5:0.25:0.25:0.1; 1 ml) for 4 h 
at room temperature. The mixture was then filtered and the resin washed with TFA (3 
× 0.5 ml). The combined filtrants were treated with dry diethyl ether (20 ml) and 
cooled to 0 °C. The precipitate was pelleted by centrifugation at 14000 g for 10 min 
and triturated with diethyl ether (20 ml) before repeating the centrifugation/trituration 
process a further 2 times and drying the pellet in vacuo to give the crude product.  
 
Peptide Purification and Analysis 
The crude product was dissolved in TFE (1.5 ml) for purification. Three eluants were 
used for HPLC purification: 80% HFIP/TFE (10% v/v; eluant A), TFA/MeCN (0.1% 
v/v; eluant B) and 20% TFA/water (0.1% v/v; eluant C). HFIP and TFE were 
obtained from Fluorochem and distilled prior to use. Other solvents were of HPLC 
grade from Fisher Scientific. Chromatography was performed on a Supelcosil LC-8 
(C8) column (Supelco; 25 cm × 1 cm) using isocratic elution between 0 and 6 min 
with an eluant composition of 80% A and 20% C, followed by a linear gradient 
between 6 and 9 min of 80-50% A, 0-50% B and 20-0% C. The flow rate was 2 
ml/min throughout. Retention times were 7.23 min (1) and 6.56 min (2). Fractions 
corresponding to the top of peaks in the elution profile were collected manually, 
pooled and concentrated in vacuo before being rechromatographed. Fractions from 
the base of peaks were pooled separately and subjected to a further two rounds of 
chromatography, producing final yields of 0.6 µmol (19%) for 1 and 0.2 µmol (12%) 
for 2, (based on the maximum theoretical yield for 50 mg of resin). Peptides were 
analyzed by MALDI mass spectrometry on a Voyager-DE STR apparatus using a 
stainless steel target. Peptides and matrix (HABA) were codissolved in HFIP at a 
molar ratio of 1:1400 to 1:3000 and 1 μl of the solution spotted on to the MALDI 
target. Calculated for linear allyl ester of 1: C161H236N38O59Na requires m/z 3670.81; found 3670.54, [M + Na]+. Calculated for linear allyl ester of 2: C165H238N40O57Na requires m/z 3716.88; found 3716.35, [M + Na]+. Calculated for 1: C158H228N38O58Na3 requires m/z 3656.69; found 3656.73, [M + 3Na - 2H]+. Calculated for 2: 
C162H230N40O56Na3 requires m/z 3702.76; found 3702.77, [M + 3Na - 2H]+. Stock solutions of the peptides were prepared in TFE and their concentrations 
determined through absorbance measurements at 280 nm following dilution of small 
aliquots into water (extinction coefficients were calculated as ε=8940 mol−1 cm−1 and 
ε=16960 mol−1 cm−1 at 280 nm for 1 and 2 respectively). (27) 
 
Liposome Preparation 
A solution of egg phosphatidylcholine (100 µl, 10 mg) was concentrated in vacuo in a 
25 ml round bottomed flask to form a thin film that was dried in vacuo overnight. The 
lipid film was hydrated with 1 ml of aqueous medium containing 150 mM NaCl 
buffered with 10 mM tris at pH 7.4 and mixed thoroughly before being subjected to 5 
freeze thaw cycles and extruded 10 times through 100 nm laser-etched polycarbonate 
membranes at 30 °C using a thermobarrel extruder (Northern Lipids). 
 
Circular and Linear Dichroism Spectroscopy 
Experiments were performed on Jasco J-810 (CD) or Jasco J-715 (LD) 
spectropolarimeters and processed using the Jasco Spectra Analysis software. All 
experiments were performed in 10 mM tris buffer at pH 7.4 containing 150 mM NaCl 
using a 1 cm quartz cell (CD) or a purpose made 50 µl quartz Couette cell (LD) (19) 
at 25 °C. A portion of the stock solution of the peptide in TFE was added to the 
aqueous medium containing liposomes at concentrations in the range 1.5-1.82 mg/ml 
(ca. 2 mM) and mixed by gentle shaking, producing peptide concentrations in the 
range 0.34−10.1 µM. Volumes were selected such that the proportion of TFE was 
never greater than 10% v/v. Time series spectra were acquired between 350 and 190 
nm at a scan rate of 10 nm/min, with a response time of 16 s and a bandwidth of 2 
nm. Blank spectra were recorded following the addition of identical quantities of pure 
TFE to the aqueous medium and subtracted from the raw time series spectra. LD 
spectra were further processed using 15-point binomial smoothing, before analysis. 
Data from time series acquisitions were fitted to two or three-state models (Fig. 2) 
using Eq. 1 ([P]3 and LD3 = 0 for the 2-state model).  
! 
LDcalc =
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[P]T
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where [P]1, [P]2 and [P]3 are the concentrations of peptide in states 1, 2 and 3 respectively, and LD1, LD2 and LD3 are the LD signals corresponding to these states. [P]T is the total concentration of peptide. LDobs is the observed LD signal.  
Concentrations of the peptides in each state were calculated according to Eqs. 2-4: 
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where k1, k2 and k3 are the rate constants for the formation of states 1–3 and t is time. With k3 = 0, Eqs. 3 and 4 revert to those for a 2-state model.  
For the purposes of these calculations, time t at which the instrument was at a given 
wavelength (λt) on each independently collected scan could be related to the scan rate 
using Eq. 5: 
 
! 
t = "s # "t + n("s # "e )s         (5) 
 
where λs is the starting wavelength of each scan, λe is the end wavelength of the scan, 
λt is the wavelength of the monochromator at time t, s is the scan rate in nm/min and n 
is an integer corresponding to the number of completed scans (n = 0, 1, 2…). Global 
least squares fitting to shared rate constants (k1, k2 and k3) was performed using the data from four wavelengths (193 nm, 228 nm, 245 nm and 254 nm) in order to 
calculate LD evolution profiles (LDcalc). Non-linear least squares curve fitting procedures were performed using the Solver function in the program Excel (Microsoft 
Corp.). The rate constants determined from the above process were then used to 
evaluate the LD parameters at all wavelengths by non-linear least squares fitting, to 
generate the full LD spectrum for each of the bound states. 
 
Results 
Peptide Synthesis 
Peptides 1 and 2 were synthesized in moderate yield using an approach based on 
coupling the majority of the amino acids as pseudoproline dipeptides. This approach 
was expected to enable assembly of the peptide chains whilst minimising the 
formation of non-productive conformations and favour the final cyclization process. 
In order to further facilitate cyclization, the syntheses were performed on a solid 
support with a polyethylene glycol (PEG) spacer in order to ensure that the reaction 
occurred in more solution-like conditions. The use of an allyl group as orthogonal 
protection for the first amino acid proved successful, although it was necessary to 
prepare fresh Pd(PPh3)4 in-house (see supporting information) in order for the deprotection to proceed to completion. Analysis of small portions of cleaved resin by 
mass spectrometry prior to cyclization indicated that the chain had been assembled 
successfully. Minor peaks at lower mass than the target peptide were consistent with 
small amounts of peptide for which coupling of Fmoc-Val-Ser(ψMe,MePro)-OH had not 
gone to completion, but at levels that were not detrimental to isolation of the target 
peptides. Cyclization and cleavage proceeded without difficulties, to yield the crude 
peptides. As anticipated, these were not trivial to manipulate due to the lack of 
charged residues and high amphiphilicity. Nevertheless, successful purification to 
≥90% was reproducibly achieved through the use of fluorinated alcohols as the 
principal solvents. Once solubilized, peptide solutions could be diluted in to aqueous 
media at solvent compositions ≤ 10% alcohol by volume and remained stable over 
several hours.  
 
Liposome Binding Experiments 
Both peptides exhibited CD spectra in solution in the absence of membranes that were 
consistent with random coil conformations (see supporting information). Furthermore, 
at the concentrations used for these experiments there was no evidence of 
aggregation. Following addition to liposomes, CD spectra were produced that were 
consistent with rapid association to the liposomal membranes (Fig. 3, A and B). Single 
minima at 213 nm and 216 nm were observed for 1 and 2 respectively, similar to 
those observed for β-barrel membrane proteins (28) and consistent with the adoption 
of β-structure. Due to the high salt conditions and path lengths used for CD 
experiments, data could not be recorded at wavelengths < 210 nm. The profiles of the 
CD spectra exhibited by both peptides did not change significantly during the course 
of the experiments. LD measurements over the same time period (Fig. 3, C and D) 
yielded spectra indicative of changes in membrane alignment occurring on a timescale 
of minutes to hours. During these measurements, the LD signal remained positive at 
all wavelengths, with notable shoulders observed in the regions of 190−195 nm and 
245−250 nm for both peptides and additional shoulders at 227 nm and 291 nm for 
peptide 2.  
 
Least Squares Fitting of the Experimental Data  
LD data were analyzed using kinetic models that assumed pseudo-first order kinetics 
for consecutive processes. This was reasonable, given the combination of the excess 
lipid used in the experiments and the likelihood that the early phases in the binding of 
peptides to membranes do not involve aggregates. Examination of semi-log plots for 
the evolution of the LD signal (Fig. 4, A and B) support these models, particularly for 
peptide 2, where it is evident that the semi-log plot consists of two processes with 
strikingly linear rate profiles. For peptide 1, the data could be modeled adequately 
using a triple exponential model (Eqs. 1−5). Applying a double exponential model for 
peptide 1 yielded inferior fits to the experimental data.  Data from four wavelengths 
corresponding to regions with the major shoulders in the LD spectra were used for the 
analysis of both peptides. Global least-squares fitting to shared rate constant values 
yielded good fits to the experimental data for both peptides (Table 1).  
The binding of peptide 1 (Fig. 4 C) was characterized by three processes, with k1 > k2 
≈ k3. The calculated LD values for each of the bound states are indicative of an 
initially weakly-oriented state (P1, formed with rate constant k1) with low LD. The 
peptide then converts to a considerably more oriented state (P2, formed with rate 
constant k2) before relaxing to a state with intermediate LD values (LD3, formed with 
rate constant k3).  For peptide 2 (Fig. 4 D), two processes were characterized, with k1 
> k2. As with peptide 1, a state with low orientation forms with rapid kinetics before 
converting to a state that is considerably more ordered. 
 
Calculation of the LD parameters at all wavelengths using the kinetic parameters in 
Table 1 enabled the LD spectra corresponding to each of the bound states to be 
determined (Fig. 5). In the case of peptide 1 (Fig. 5 A), the initial bound state (P1) is 
characterized by an LD spectrum (LD1) that is relatively weak across the whole 
spectrum, but has a pronounced maximum at 246 nm and a shoulder at ~275 nm. This 
gives way to spectra (LD2 and LD3, Fig. 5 A) exhibiting significantly higher LD 
values in the far-UV range, with a significant maximum at 193 nm. Interestingly, 
changes in the near-UV spectrum are considerably smaller than those of the far-UV 
for both of these bound states. The spectrum of the initial bound state of peptide 2 
(LD1, Fig. 5 B) shares similar features with that of peptide 1, with a maximum at 249 
nm and a shoulder at 292 nm. This also gives way to a spectrum (LD2, Fig. 5 B) with 
higher LD values in the far-UV range and smaller changes in the near-UV, but with a 
shoulder at 228 nm in addition to the maximum at 192 nm. 
 
One feature enabled by the non-linear regression using this model is the ability to 
calculate the concentration of all intermediates throughout the experiment. This gives 
rise to the concentration profiles in Fig. 6. For both peptides, the initially formed state 
(P1) forms rapidly and then decays exponentially to zero during the period of the 
experiments. In the case of peptide 2, the final state (P2) forms completely during the 
same period. With peptide 1, this state exists as a transient intermediate, decaying to 
zero and being replaced by the final state (P3). 
 
Discussion  
Peptides 1 and 2 were designed following bioinformatics exercises on β-barrel 
membrane proteins on the basis that, due to their hydrophobicity and amphiphilicity, 
membrane association would be favoured (24). Their cyclic nature was intended to 
promote the formation of secondary structure following membrane binding and render 
analysis of insertion processes more straightforward, as the issue of which end of the 
peptide inserts into the membrane first would not be a consideration.   
Both peptides adopt random coil conformations in aqueous solution at concentrations 
< 20 µM in the absence of membranes. However, following addition to membranes, 
secondary structure forms rapidly and once formed, remains unchanged for the 
duration of the experiment. As a consequence, LD data can be interpreted with the 
certainty that they reflect only changes in alignment with respect to the experimental 
frame of reference and do not contain contributions from secondary structure changes. 
It further enables LD profiles at all wavelengths to be simultaneously fitted to the 
same kinetics parameters, improving the reliability of data analysis. The purpose of 
this study was to explore the possibilities for using LD to probe the membrane-
association kinetics of two peptides designed to undergo insertion, by assaying 
relative changes in alignment. As such, it was not necessary to use an internal 
reference in order to define the experimental frame of reference, as has been 
described elsewhere (29). For this work, the semi-quantitative assessment made here 
enables us to extract the mechanistic information required. 
Non-linear fitting of the model described by Eqs. 1-5 produced good fits to the 
experimental data for both peptides. Two processes are common to both peptides. The 
first (k1) is a rapid process that leads to a bound state (P1) characterized by a weak positive LD spectrum with distinct maxima and shoulders in the near-UV that 
correspond closest to the La and Lb transitions of tyrosine and tryptophan (20). The Lb 
transition of tyrosine is oriented normal to the Cβ-C1-C4-O axis and is usually found in 
the region of 260 nm, although transitions in the region of 250 nm have been reported 
for β-rich proteins with a high aromatic amino acid content, such as retinol binding 
protein (30). Tryptophan has an La transition occurring at ~265 nm that lies on an axis that bisects the indole N1-C4 atoms and an Lb transition at 287 nm oriented orthogonally to the La transition. The deconvoluted LD spectrum for P1 is consistent with a state that is weakly bound to the membrane through the side chains of aromatic 
residues, leading to alignment of these side chains, with the peptide backbone either 
poorly aligned or aligned close to 54.7° with respect to the membrane normal (which 
would also give a weak signal) (22). As the wavelengths corresponding to these bands 
are red-shifted by approximately 5 nm in peptide 2 with respect to the corresponding 
bands of peptide 1, indicating that they arise from the tryptophan residues of the 
former, it would seem that the residues near the ends of the peptides as depicted in 
Fig. 1 are those that are primarily participating in interactions, although it does not 
rule out contributions from the others. Positive LD bands for both La and Lb of tryptophan have been observed in other systems (23) and are indicative of the indole 
side chain being oriented perpendicular to the membrane normal. In these studies, the 
same rationale can be applied to the phenolic side chain of tyrosine. The observation 
of a spectrum that is positive across the wavelength range suggests that the alignment 
of the peptide as a whole is nearer to the membrane normal than the plane of the 
membrane, as the main amide transitions in β-hairpins that contribute to the far-UV 
region have a cross strand orientation. Taken together, these observations are 
consistent with an anchoring interaction of a small number of residues with the 
membrane surface. It is noteworthy that the signals corresponding to the Lb transitions of tyrosine and tryptophan do not change significantly throughout the duration of the 
experiment, which suggests that some of the side chain interactions are relatively 
strong and implies that changes in alignment of the peptide backbone are 
accommodated by changes in the side chain torsional angles.  
The second process (k2) is characterized by surprisingly slow kinetics, which was not anticipated at the outset of this work. The spectrum of the bound state (P2) has significantly more positive LD values across the spectrum, particularly for the 190 nm 
region (corresponding to the π-π* transition of the backbone), indicative of an 
alignment that is closer to the membrane normal than P1. Accounts of kinetic processes for the binding of peptides to membranes with half-lives of the order of ~ 1 
h are rare. White and co-workers reported conditions under which a designed helical 
peptide underwent slow membrane insertion kinetics, on a timescale of hours, 
although this phenomenon was only observed at non-physiological pH values (≤ pH 
5.3). (16) It will be of interest to determine whether peptide rearrangements on these 
timescales are a general phenomenon or a property particular to these peptides. Earlier 
studies on marker release by peptide 1 indicated that apparent poration of EPC 
membranes occurs on a time scale of seconds to minutes (24), which is more 
consistent with the kinetics of k1 than k2, raising the possibility that membrane disruption primarily occurs during the initial binding process, rather than by specific 
poration. An explanation for the slow kinetics lies in the lack of charge 
complementaity between the peptides and the membrane, both of which are neutral in 
the physiological pH range. Given the low molar peptide:lipid ratios (typically 
1:1000) and that the peptides do not promote significant changes in lipid morphology 
at higher ratios (24), the changes in LD can be assigned to changes in peptide 
orientation. 
A third kinetic process is observed for peptide 1, but not peptide 2. This also occurs 
on a slow timescale, and leads to a diminution of positive LD values, consistent with 
the adoption of a conformation that lies further away from the membrane normal. One 
possibility is that this represents a realignment of peptide 1 in order to minimize the 
effects of mismatch (31,32) between the peptide and the membrane or promote 
peptide aggregation, whereas peptide 2 does not realign due to the known anchoring 
effects of tryptophan in the interfacial region of lipid membranes (9), which would 
favour lipid redistribution as a means of overcoming mismatch. 
 
One study of the refolding of a β-barrel outer membrane protein reported three 
processes with kinetics on a similar timescale to those reported here (33). Of these, a 
moderately slow process with a timescale of minutes was attributed to the formation 
of a partially folded state within the membrane, with the slower process on a 
timescale of hours attributed to adoption of the folded state. These are broadly similar 
to the processes observed here, indicating that these peptides may prove to be good 
models for transmembrane β-barrels. A model for the behaviour of these peptides is 
shown schematically in Fig. 7.  
 
The peptides form secondary structure on a timescale that is more rapid than k1. The full description of binding therefore requires at least one additional rate constant to be 
included in the process depicted in Fig. 7. An advantage of the rapid adoption of 
secondary structure, however, is that changes in LD relate only to changes in peptide 
orientation, enabling us to interpret the LD data more definitively than if folding and 
insertion were coupled. The data illustrate that the LD methodology is a useful tool 
for probing membrane adorbtion kinetics that is of general applicability to systems 
where confomational changes during adsorbtion can be assayed. 
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Table 1 Parameters obtained from non-linear least squares fitting of the model 
described by Eqs. 1-5 to the experimental data for the binding of peptides 1 and 2 at 
respective concentrations of 1.05 µM and 0.34 µM to EPC liposomes (1.5 mg/ml; 2 
mM) in 10 mM tris/150 mM NaCl at pH 7.4. 
Peptide 1* 2* 
k1 / min-1 1.01 ± 0.20 1.62 ± 0.47 
k2 / min-1 0.013 ± 0.001 0.010 ± 0.001 
k3 / min-1 0.013 ± 0.001 - 
τ1 / min 0.99 ± 0.19 0.62 ± 0.18 
τ2 / min 76.3 ± 5.9 98.6 ± 9.7 
τ3 / min 76.4 ± 5.9 - 
LD1 570 ± 13 1649 ± 9 
LD2 2130 ± 79 3874 ± 4 193 nm 
LD3 1340 ± 20 - 
LD1 377 ± 2 706 ± 7 
LD2 909 ± 37 1286 ± 5 228 nm 
LD3 659 ± 10 - 
LD1 423 ± 9 662 ± 2 
LD2 739 ± 12 1715 ± 1 245 nm 
LD3 505 ± 4 - 
LD1 300 ± 3 631 ± 4 
LD2 482 ± 7 1142 ± 2 
LD / 
AU 
mol-1 
dm3 
254 nm 
LD3 352 + 4 - 
* Errors are reported to 95% confidence limits and were estimated by repeating the 
non-linear regression ten times from random estimates of the variables.
Figure Legends 
 
Figure 1 Structures of the cyclic peptides described in this work. 
 
Figure 2 The kinetics model used for analysis of LD data. 
 
Figure 3 Time series spectra acquired at 20 °C over an 8 h period following the 
addition of peptides to 100 nm EPC liposomes in 10 mM tris/150 mM NaCl at pH 
7.4. CD spectra for 1 (A) and 2 (B) at respective peptide concentrations of 10.1 µM 
and 3.23 µM and an EPC concentration of 1.82 mg/ml (2 mM); LD spectra for 1 (C) 
and 2 (D) at respective peptide concentrations of 1.05 µM and 0.34 µM and an EPC 
concentration of 1.5 mg/ml (2 mM). The legend associated with each LD spectrum 
indicates the time (min) after which acquisition of the corresponding spectrum 
commenced. 
 
Figure 4 The evolution of LD signals following the addition of peptides 1 and 2 at 
respective concentrations of 1.05 µM and 0.34 µM to EPC liposomes (1.5 mg/ml; 2 
mM) in 10 mM tris/150 mM NaCl at pH 7.4: semi-log plots for peptide 1 at 193 nm 
(A) and 2 at 228 nm (B); experimental and calculated profiles for peptides 1 (C) and 2 
(D) at 193 nm (), 228 nm (▲), 245 nm () and 254 nm (). Experimental data are 
presented as points and the calculated profiles from non-linear regression as lines. 
 
Figure 5 LD spectra for each binding state described by Eq. 1, calculated by 
regression analysis of the binding profiles for the association of peptides 1 (A) and 2 
(B) with EPC liposomes in 10 mM tris/150 mM NaCl at pH 7.4. The identity of the 
binding state is indicated by the text associated with each spectrum. 
 
Figure 6 Concentrations of each of the liposome-bound states following addition of 
peptides 1 (A) and 2 (B) at respective concentrations of 1.05 µM and 0.34 µM to EPC 
liposomes (1.5 mg/ml; 2 mM) in 10 mM tris/150 mM NaCl at pH 7.4, calculated by 
fitting of Eq. 1 to the experimental data by non-linear regression. Key: [P]1 – – – – ; 
[P]2 ⎯⎯ ; [P]3 ------. 
 
Figure 7 Peptide binding conformations consistent with the calculated LD spectra for 
binding states of peptides 1 and 2. The membrane is represented by the hatched boxes 
and the peptide by clear rectangles. 
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